A novel preoperative model to predict 90-day surgical mortality in patients considered for renal cell carcinoma surgery

Kidney cancer is the 8th leading cancer diagnosis in the United States with an estimated 63,990 of new cases resulting in 14,400 deaths based on 2016 data [1]. In contrast to many of the other most commonly diagnosed malignancies, the incidence of kidney cancer has risen over the last few decades in men and women of every racial and ethnic group [2]. The rise in incidence of kidney cancer has coincided with a downward drift stage migration likely secondary to the more frequent diagnosis of small, incidental renal masses on cross-sectional imaging [3 –6].
Source: Urologic Oncology: Seminars and Original Investigations - Category: Urology & Nephrology Authors: Source Type: research